1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Panic Disorders Global Clinical Trials Review, H2, 2014

Panic Disorders Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Panic Disorders Global Clinical Trials Review, H2, 2014" provides data on the Panic Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Panic Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Panic Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Panic Disorders Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Panic Disorders 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Panic Disorders 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Panic Disorders Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
ZonMw 35
Clinical Trial Overview of ZonMw 35
Bluefish Pharmaceuticals AB 36
Clinical Trial Overview of Bluefish Pharmaceuticals AB 36
Teva Pharmaceutical Industries Limited 37
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 37
Alexza Pharmaceuticals, Inc. 38
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 38
Actavis plc 39
Clinical Trial Overview of Actavis plc 39
Abiogen Pharma S.p.A. 40
Clinical Trial Overview of Abiogen Pharma S.p.A. 40
Clinical Trial Overview of Top Institutes / Government 41
National Institute of Mental Health 41
Clinical Trial Overview of National Institute of Mental Health 41
Massachusetts General Hospital 42
Clinical Trial Overview of Massachusetts General Hospital 42
The University of New South Wales 43
Clinical Trial Overview of The University of New South Wales 43
Charite - Universitatsmedizin Berlin 44
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Samsung Medical Center 46
Clinical Trial Overview of Samsung Medical Center 46
Maastricht University Medical Center 47
Clinical Trial Overview of Maastricht University Medical Center 47
Karolinska Institute 48
Clinical Trial Overview of Karolinska Institute 48
Federal University of Rio de Janeiro 49
Clinical Trial Overview of Federal University of Rio de Janeiro 49
Maastricht University 50
Clinical Trial Overview of Maastricht University 50
Five Key Clinical Profiles 51
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Panic Disorders Therapeutics, Global, Clinical Trials by Region, 2014* 7
Panic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Panic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Panic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Panic Disorders Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Panic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Panic Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Panic Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Panic Disorders Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Panic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Panic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Panic Disorders Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Panic Disorders Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Panic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Panic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Panic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Panic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Panic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 32
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014* 35
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 36
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 37
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexza Pharmaceuticals, Inc., 2014* 38
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 39
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Abiogen Pharma S.p.A., 2014* 40
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 41
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 42
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014* 43
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 44
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 45
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 46
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 47
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 48
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Rio de Janeiro, 2014* 49
Panic Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University, 2014* 50

List of Figures
Panic Disorders Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Panic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Panic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Panic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Panic Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Panic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Panic Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Panic Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Panic Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Panic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Panic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Panic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Panic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Panic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Panic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Panic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.